Related Experiment Video
Updated: Jul 28, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Analysis of hydroxychloroquine prescriptions for COVID-19 in Japan
Takashi Watari1,2, Yasuharu Tokuda3,4, Hiromizu Takahashi5
1General Medicine Center Shimane University Shimane Japan.
Insights
Monthly hydroxychloroquine prescriptions for COVID-19 in Japan were tracked from January 2020 to November 2021. Prescription trends were compared against national COVID-19 case notifications.
Area of Science:
- Pharmacology
- Infectious Diseases
- Epidemiology
Background:
- Hydroxychloroquine was investigated as a potential treatment for coronavirus disease 2019 (COVID-19).
- Understanding prescription patterns is crucial for assessing treatment uptake during the pandemic.
Purpose of the Study:
- To analyze the monthly prescription trends of hydroxychloroquine for COVID-19 patients in Japan.
- To compare hydroxychloroquine prescription data with national COVID-19 case counts.
Main Methods:
- Utilized the Medical Data Vision database, covering approximately 20% of acute care hospitals in Japan.
- Collected monthly hydroxychloroquine prescription data from January 2020 to November 2021.
- Correlated prescription data with monthly national COVID-19 notifications.
Main Results:
- The study presents monthly hydroxychloroquine prescription data (blue bars) and national COVID-19 notifications (gray line).
- Visual representation allows for direct comparison of drug prescription trends against disease prevalence.
Conclusions:
- The data provides insights into the clinical use of hydroxychloroquine for COVID-19 in Japan during a specific period.
- Further analysis can explore the relationship between prescription patterns and public health guidelines or research findings.
Abstract:
Number of hydroxychloroquine prescriptions per month for patients with coronavirus disease 2019 (COVID-19) in Japan from January 2020 to November 2021. The blue bars show the monthly number of chloroquine prescriptions for COVID-19 among patients in the Medical Data Vision database, which includes data on approximately 20% of acute care hospitals in Japan. The gray line shows the national number of COVID-19 notifications in Japan by month over the same period.
More Related Videos
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Pareto Chart
The Pareto chart is named after the Italian economist Vilfredo Pareto, who described the Pareto...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Time Course of Drug Effect
Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...

